Author: ALAN R. ELLIOTT
Source
San Francisco-based Nurix Therapeutics reported robust results in an ongoing treatment against a stubborn form of leukemia.
The post Biotech Stock Nurix Therapeutics Jumps On Positive Leukemia Treatment Trial appeared first on Investor’s Business Daily.